⚠ Official Notice: www.ijisrt.com is the official website of the International Journal of Innovative Science and Research Technology (IJISRT) Journal for research paper submission and publication. Please beware of fake or duplicate websites using the IJISRT name.



Crystal Engineering of Carbamazepine Co-Crystals for Solubility and Dissolution Enhancement: Solid-State Characterization and In-Vitro Performance Evaluation


Authors : Anil Kumar; Dr. Vikas Gupta

Volume/Issue : Volume 11 - 2026, Issue 10 - October


Google Scholar : https://tinyurl.com/3prexhrh

DOI : https://doi.org/10.38124/ijisrt/26Oct1685

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.


Abstract : Poor aqueous solubility remains a major limitation in oral drug delivery, particularly for Biopharmaceutics Classification System (BCS) Class II drugs. Carbamazepine (CBZ), a widely prescribed anticonvulsant, exhibits high permeability but low aqueous solubility, resulting in variable dissolution behaviour and inconsistent therapeutic response. The present study aimed to design and evaluate pharmaceutical co-crystals of carbamazepine using rational crystal engineering approaches to enhance solubility and dissolution characteristics. Cocrystals were prepared using nicotinamide, saccharin, and glutaric acid as co-formers through solvent evaporation, slurry crystallization, and liquid-assisted grinding techniques.

Keywords : Carbamazepine, Co-Crystals, Crystal Engineering, Solubility Enhancement, Dissolution Kinetics, Solid-State Characterization.

References :

  1. Abramov, Y. A., Iuzzolino, L., Jin, Y., York, G., Chen, C. H., Shultz, C. S., Yang, Z., Chang, C., Shi, B., Zhou, T., Greenwell, C., Sekharan, S., & Lee, A. Y. (2023) Cocrystal Synthesis through Crystal Structure Prediction. Mol Pharm 20:3380-3392. 10.1021/acs.molpharmaceut.2c01098
  2. Adhikari, B. R., Gordon, K. C., & Das, S. C. (2022) Solid state of inhalable high dose powders. Adv Drug Deliv Rev 189:114468. 10.1016/j.addr.2022.114468
  3. Aikawa, S., Tanaka, H., Ueda, H., Maruyama, M., & Higaki, K. (2022) Formation of a Stable Co-Amorphous System for a Brick Dust Molecule by Utilizing Sodium Taurocholate with High Glass Transition Temperature. Pharmaceutics 15:10.3390/pharmaceutics15010084
  4. Al-Nimry, S. S., & Khanfar, M. S. (2022) Enhancement of the Solubility of Asenapine Maleate Through the Preparation of Co-Crystals. Curr Drug Deliv 19:788-800. 10.2174/1567201818666210805154345
  5. Alkalla, N., Alhalaweh, A., Bergström, C. A. S., Li, N., & Taylor, L. S. (2026) Coadministration of a crystalline drug compromises supersaturation and membrane transport of an amorphous drug. Int J Pharm 687:126388.10.1016/j.ijpharm.2025.126388
  6. Aytekin, E., Kaya, M. Z., İlkar, G. E., Polat, H. K., Öztürk, N., Vural, İ., Çakmak, H. B., Çelebier, M., Palaska, E., Çalış, S., & Bozdağ Pehlivan, S. (2025) Optimizing riboflavin delivery with co-crystal and in situ hydrogel formulations for management of keratoconus: A comprehensive investigation with in vitro, ex vivo and in vivo studies. Int J Pharm 674:125435. 10.1016/j.ijpharm.2025.125435
  7. Bairagi, K. M., Ingle, K. S., Bhowal, R., Mohurle, S. A., Hasija, A., Alwassil, O. I., Venugopala, K. N., Chopra, D., & Nayak, S. K. (2021) Interplay of Halogen and Hydrogen Bonding through Co-Crystallization in Pharmacologically Active Dihydropyrimidines: Insights from Crystal Structure and Energy Framework. Chempluschem 86:1167-1176. 10.1002/cplu.202100259
  8. Biscaia, I. F. B., Gomes, S. N., Bernardi, L. S., & Oliveira, P. R. (2021) Obtaining Cocrystals by Reaction Crystallization Method: Pharmaceutical Applications. Pharmaceutics 13:10.3390/pharmaceutics13060898
  9. C, A., N, J., R, P. R., S, H., P, R., A, S., & S, J. (2026) Solubility enhancement of rosuvastatin using co-crystal approach. Drug Dev Ind Pharm 52:617-625. 10.1080/03639045.2026.2624588
  10. Chen, Y., Lubach, J. W., Tang, S., & Narang, A. S. (2021) Effect of Counterions on Dissolution of Amorphous Solid Dispersions Studied by Surface Area Normalized Dissolution. Mol Pharm 18:3429-3438. 10.1021/acs.molpharmaceut.1c00325
  11. Du, Y., Frank, D., Chen, Z., Struppe, J., & Su, Y. (2023) Ultrafast magic angle spinning NMR characterization of pharmaceutical solid polymorphism: A posaconazole example. J Magn Reson 346:107352. 10.1016/j.jmr.2022.107352
  12. Elshaer, M., Osman, S. K., Mohammed, A. M., & Zayed, G. (2024) Co-crystallization of Hesperidin with different co-formers to enhance solubility, antioxidant and anti-inflammatory activities. Pharm Dev Technol 29:691-702.10.1080/10837450.2024.2378498
  13. Fayed, N. D., Arafa, M. F., Essa, E. A., & El Maghraby, G. M. (2022) Lopinavir-menthol cocrystals for enhanced dissolution rate and intestinal absorption. J Drug Deliv Sci Technol 74:103587. 10.1016/j.jddst.2022.103587
  14. Furuishi, T., Sato-Hata, N., Fukuzawa, K., & Yonemochi, E. (2023) Characterization of coamorphous carvedilol-maleic acid system prepared by solvent evaporation. Pharm Dev Technol 28:309-317. 10.1080/10837450.2023.2194406
  15. Guo, M., Sun, X., Chen, J., & Cai, T. (2021) Pharmaceutical cocrystals: A review of preparations, physicochemical properties and applications. Acta Pharm Sin B 11:2537-2564. 10.1016/j.apsb.2021.03.030
  16. Ibraheem, B., & Wagner, K. G. (2021) Influence of high pressure compaction on solubility and intrinsic dissolution of ibuprofen binary mixtures employing standard excipients. Int J Pharm X 3:100075. 10.1016/j.ijpx.2021.100075
  17. Kumar Bandaru, R., Rout, S. R., Kenguva, G., Gorain, B., Alhakamy, N. A., Kesharwani, P., & Dandela, R. (2021) Recent Advances in Pharmaceutical Cocrystals: From Bench to Market. Front Pharmacol 12:780582. 10.3389/fphar.2021.780582
  18. Li, R., Sun, J., Luo, K., Luo, N., Sun, R., Gao, F., Wang, Y., Xia, Y., Li, X., Chen, L., Ma, R., Shao, X., Liang, Y., & Fang, J. (2024) Electroacupuncture and carbamazepine for patients with trigeminal neuralgia: a randomized, controlled, 2 × 2 factorial trial. J Neurol 271:5122-5136. 10.1007/s00415-024-12433-x
  19. Liu, J., Klinzing, G. R., & Nie, H. (2023) Effect of Material Properties and Variability of Mannitol on Tablet Formulation Development. Pharm Res 40:2071-2085. 10.1007/s11095-023-03577-y
  20. Lösing, H., Eriksen, J. B., Scherließ, R., & Bauer-Brandl, A. (2023) Inexpensive and Easy-ToUse Alternative to the Die Holder for Pharmacopoeial Intrinsic Dissolution Tests. J Pharm Sci 112:2292-2296. 10.1016/j.xphs.2023.02.020
  21. Luebbert, C., & Stoyanov, E. (2023) Tailored ASD destabilization - Balancing shelf life stability and dissolution performance with hydroxypropyl cellulose. Int J Pharm X 5:100187. 10.1016/j.ijpx.2023.100187
  22. Nagamatsu, D., Ando, S., Fujimura, Y., Miyano, T., Sugita, K., & Ueda, H. (2023) Formation of Hemihydrate Crystal form Overcomes Milling Issue Induced by Exposed Functional Groups on Cleavage Plane for a Y5 Receptor Antagonist of Neuropeptide Y. J Pharm Sci 112:2516-2523. 10.1016/j.xphs.2023.04.012
  23. Ohashi, R., Otake, S., Murata, T., Watari, R., Yoshida, S., Kitade, M., Kondo, D., & Kimura, G. (2025) Selection of Solubility Enhancement Technologies for S-892216, a Novel COVID-19 Drug Candidate. Pharmaceutics 17:10.3390/pharmaceutics17121627
  24. Paul, S., Guo, Y., Wang, C., Dun, J., & Calvin Sun, C. (2023) Enabling direct compression tablet formulation of celecoxib by simultaneously eliminating punch sticking, improving manufacturability, and enhancing dissolution through co-processing with a mesoporous carrier. Int J Pharm 641:123041. 10.1016/j.ijpharm.2023.123041
  25. Pérez Palacios, A. F., Medina Parra, J. A., Córdoba Velasco, D. S., Zona Rubio, D. C., Alves, I. A., & Aragón Novoa, D. M. (2025) New Strategies to Improve Drug Solubility and Its Impact on Bioavailability: A Patent Review (2015-2024). AAPS PharmSciTech 27:57. 10.1208/s12249-025-03287-1
  26. Porat, D., Margolin, N., Lavon, O., & Dahan, A. (2022) Carbamazepine Therapy After Bariatric Surgery: Eight Sleeve Gastrectomy Cases and Review of the Literature. Obes Surg 32:3481-3486. 10.1007/s11695-022-06247-x
  27. Shelke, S. J., Bhangare, D. H., & Patil, M. D. (2025) Pharmaceutical Cocrystals: A Review on Design, Preparation, Application and Challenges. Zhongguo Ying Yong Sheng Li Xue Za Zhi 41:e20250022. 10.62958/j.cjap.2025.022
  28. Tomar, D., Mainuddin, Anshika, & Jindal, A. (2025) Nano-cocrystals as Nanotechnologybased Approach to Modulate Solubility and Bioavailability of Poorly Soluble Drugs. Curr Top Med Chem 10.2174/0115680266379743250717181526
  29. Verma, P., Srivastava, A., Srivastava, K., Tandon, P., & Shimpi, M. R. (2021) Molecular Structure, Spectral Investigations, Hydrogen Bonding Interactions and ReactivityProperty Relationship of Caffeine-Citric Acid Cocrystal by Experimental and DFT Approach. Front Chem 9:708538. 10.3389/fchem.2021.708538
  30. Wang, L., Wang, Y., Zhang, R. Y., Wang, Y., Liang, W., & Li, T. G. (2023) Management of acute carbamazepine poisoning: A narrative review. World J Psychiatry 13:816-830. 10.5498/wjp.v13.i11.816
  31. Wu, H., Wang, Z., Zhao, Y., Gao, Y., Wang, L., Zhang, H., Bu, R., Ding, Z., & Han, J. (2023) Effect of different seed crystals on the supersaturation state of ritonavir tablets prepared by hot-melt extrusion. Eur J Pharm Sci 185:106440. 10.1016/j.ejps.2023.106440
  32. Yarlagadda, D. L., Sai Krishna Anand, V., Nair, A. R., Navya Sree, K. S., Dengale, S. J., & Bhat, K. (2021) Considerations for the selection of co-formers in the preparation of coamorphous formulations. Int J Pharm 602:120649. 10.1016/j.ijpharm.2021.120649
  33. Yokoo, H., Koide, T., Miyazaki, T., Aoyama, Y., Ogaeri, Y., Yamamoto, E., Demizu, Y., & Uchiyama, N. (2025) Combination of Microcrystal Electron Diffraction and Solid-State NMR for the Structural Determination of Indomethacin-Nicotinamide Co-crystals. Chem Pharm Bull (Tokyo) 73:813-818. 10.1248/cpb.c25-00377

Poor aqueous solubility remains a major limitation in oral drug delivery, particularly for Biopharmaceutics Classification System (BCS) Class II drugs. Carbamazepine (CBZ), a widely prescribed anticonvulsant, exhibits high permeability but low aqueous solubility, resulting in variable dissolution behaviour and inconsistent therapeutic response. The present study aimed to design and evaluate pharmaceutical co-crystals of carbamazepine using rational crystal engineering approaches to enhance solubility and dissolution characteristics. Cocrystals were prepared using nicotinamide, saccharin, and glutaric acid as co-formers through solvent evaporation, slurry crystallization, and liquid-assisted grinding techniques.

Keywords : Carbamazepine, Co-Crystals, Crystal Engineering, Solubility Enhancement, Dissolution Kinetics, Solid-State Characterization.

Paper Submission Last Date
30 - November - 2026

SUBMIT YOUR PAPER CALL FOR PAPERS
Video Explanation for Published paper

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe